Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,680 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 50 of 640 · 7,680 filings

  • Decoy Therapeutics (DCOY) FY2025 10-K risk factors
    59 risks53 new33 dropped5 reworded

    Nasdaq requires the company to regain its $1.00 bid-price compliance by March 20, 2026 or face delisting.

    Filed Mar 31, 2026
  • Digi Power X (DGXX) FY2025 10-K risk factors
    56 risks

    Transitioning from bitcoin mining toward AI/HPC data centers creates infrastructure, execution, customer, and capital-allocation risks.

    Filed Mar 31, 2026
  • Dominari Holdings (DOMH) FY2025 10-K risk factors
    49 risks14 new2 dropped3 reworded

    Operating losses worsened with a net loss of $22.4 million and accumulated deficit of $268.1 million in 2025.

    Filed Mar 31, 2026
  • Direct Digital Holdings (DRCT) FY2025 10-K risk factors
    58 risks5 new8 dropped13 reworded

    Direct Digital Holdings is restructuring its go-to-market strategy around Ignition+ and buy-side customers after missing volume targets.

    Filed Mar 31, 2026
  • DSS (DSS) FY2025 10-K risk factors
    22 risks2 reworded

    Concentration risk worsened as a single customer now accounts for 29% of consolidated revenue. Secured debt repayment remains a critical risk due to history of operating losses.

    Filed Mar 31, 2026
  • Duos Technologies Group (DUOT) FY2025 10-K risk factors
    27 risks5 new2 dropped5 reworded

    Edge data centers and digital infrastructure now dominate new risks, including Texas concentration, leased sites, power, utilities, and network connectivity.

    Filed Mar 31, 2026
  • Dawson Geophysical (DWSN) FY2025 10-K risk factors
    31 risks5 new3 dropped7 reworded

    Customer concentration increased, with the largest client accounting for 51% of revenues in 2025 compared to 43% for two clients in 2024.

    Filed Mar 31, 2026
  • Edible Garden (EDBL) FY2025 10-K risk factors
    51 risks5 new3 dropped10 reworded

    The company added risks concerning smaller-scale competition, new RTD beverage lines at the Iowa facility, quality control, recalls, and internal controls.

    Filed Mar 31, 2026
  • Elauwit Connection (ELWT) FY2025 10-K risk factors
    39 risks

    Elauwit Connection reports significant historical net losses, including $4.2 million in 2025 and $3.5 million in 2024. The company depends heavily on property owners, network partners, and a single hardware manufacturer. Insiders hold 48.9 percent of voting power, and continued Nasdaq listing depends on maintaining the stock price above $1.00.

    Filed Mar 31, 2026
  • enCore Energy (EU) FY2025 10-K risk factors
    68 risks8 new7 dropped14 reworded

    enCore Energy's new risks center on $110.0 million in debt, convertible notes, marketable equity volatility, and active securities class action litigation.

    Filed Mar 31, 2026
  • Fortress Biotech (FBIO) FY2025 10-K risk factors
    63 risks3 new2 dropped6 reworded

    New government policies, tariffs on imports from India, and FDA staffing cuts pose fresh commercialization hurdles for drug products.

    Filed Mar 31, 2026
  • Forte Biosciences (FBRX) FY2025 10-K risk factors
    82 risks11 new5 dropped17 reworded

    Forte highlights its heavy reliance on its single lead candidate FB102, third-party manufacturers, and foreign trials in Australia.

    Filed Mar 31, 2026

Companies covered

4,010 companies

371 more under A